Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Wilms Tumor 5Rhabdoid Tumor 5Neuroectodermal Tumors, Primitive, Peripheral 5Neuroblastoma 5Medulloblastoma 5Lymphoma, Non-Hodgkin 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Glioma 5Ependymoma 5Sarcoma 4Rhabdomyosarcoma 4Osteosarcoma 4Central Nervous System Neoplasms 4Sarcoma, Ewing 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroendocrine Tumors 2Lung Neoplasms 2Burkitt Lymphoma 2Xanthogranuloma, Juvenile 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Non functioning pancreatic endocrine tumor 1Neoplasm Metastasis 1Lymphoma, B-Cell 1Lymphoma 1Histiocytic Sarcoma 1Familial ependymoma 1Carcinoma, Non-Small-Cell Lung 1Adenoma, Islet Cell 1

Interventions

Erlotinib Hydrochloride 2dehydroftorafur 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Gemcitabine 1Fluorouracil 1Drug Therapy 1Congresses as Topic 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pancreatic Intraductal Neoplasms × Phantoms, Imaging × Clear all
NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡